US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 118.950
  • +0.990+0.84%
Close Nov 27 16:00 ET
  • 118.950
  • 0.0000.00%
Post 19:48 ET
206.31BMarket Cap36.16P/E (TTM)

Abbott Laboratories Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
4.85%10.64B
4.00%10.38B
2.23%9.96B
-8.12%40.11B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
1.34%43.65B
-12.01%10.09B
Operating revenue
4.85%10.64B
4.00%10.38B
2.23%9.96B
-8.12%40.11B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
1.34%43.65B
-12.01%10.09B
Cost of revenue
2.02%4.7B
2.68%4.6B
3.05%4.46B
-6.10%17.98B
-0.81%4.56B
-0.52%4.61B
-9.12%4.48B
-13.15%4.33B
3.26%19.14B
-3.63%4.59B
Gross profit
7.20%5.94B
5.08%5.77B
1.57%5.5B
-9.70%22.13B
3.40%5.69B
-4.20%5.54B
-13.11%5.5B
-21.60%5.42B
-0.11%24.51B
-17.96%5.5B
Operating expense
4.81%4.08B
3.85%4.11B
5.32%4.12B
-3.05%15.66B
-6.89%3.91B
-2.99%3.89B
0.13%3.95B
-2.23%3.91B
0.22%16.15B
-3.01%4.19B
Selling and administrative expenses
6.32%2.9B
7.15%2.94B
7.13%2.96B
-2.66%10.95B
-8.38%2.72B
-0.29%2.72B
-0.62%2.74B
-0.90%2.76B
-0.67%11.25B
-2.46%2.97B
Research and development costs
6.10%713M
-2.38%698M
4.59%684M
-5.09%2.74B
-3.45%700M
-14.07%672M
4.53%715M
-6.17%654M
5.32%2.89B
-4.86%725M
Depreciation amortization depletion
-5.24%470M
-5.42%471M
-3.87%472M
-2.33%1.97B
-3.02%481M
-0.40%496M
-1.78%498M
-4.10%491M
-1.66%2.01B
-3.50%496M
-Depreciation and amortization
-5.24%470M
-5.42%471M
-3.87%472M
-2.33%1.97B
-3.02%481M
-0.40%496M
-1.78%498M
-4.10%491M
-1.66%2.01B
-3.50%496M
Operating profit
12.87%1.86B
8.24%1.67B
-8.15%1.39B
-22.53%6.48B
36.50%1.78B
-6.95%1.65B
-35.10%1.54B
-48.18%1.51B
-0.75%8.36B
-45.16%1.3B
Net non-operating interest income expense
26.09%-51M
4.92%-58M
-17.31%-61M
32.80%-252M
-6.06%-70M
19.77%-69M
42.45%-61M
55.56%-52M
23.47%-375M
45.00%-66M
Non-operating interest income
-6.19%91M
-16.33%82M
-20.79%80M
110.38%385M
1.14%89M
76.36%97M
276.92%98M
621.43%101M
325.58%183M
700.00%88M
Non-operating interest expense
-14.46%142M
-11.95%140M
-7.84%141M
14.16%637M
3.25%159M
17.73%166M
20.45%159M
16.79%153M
4.69%558M
17.56%154M
Other net income (expense)
41.94%132M
-102.58%-4M
5.71%111M
37.30%438M
3.66%85M
25.68%93M
89.02%155M
29.63%105M
15.58%319M
18.84%82M
Gain on sale of security
10.00%11M
128.57%6M
----
-1,950.00%-41M
-271.43%-24M
152.63%10M
---21M
-300.00%-6M
-100.00%-2M
133.33%14M
Other non- operating income (expenses)
45.78%121M
-105.68%-10M
0.00%111M
49.22%479M
60.29%109M
-10.75%83M
114.63%176M
42.31%111M
15.88%321M
7.94%68M
Income before tax
16.10%1.94B
-1.77%1.61B
-8.07%1.44B
-19.77%6.66B
35.98%1.8B
-4.95%1.67B
-30.44%1.64B
-45.69%1.56B
1.16%8.31B
-43.27%1.32B
Income tax
25.11%294M
16.86%305M
-13.52%211M
-31.46%941M
-29.97%201M
-27.24%235M
-21.86%261M
-43.12%244M
20.44%1.37B
-15.09%287M
Net income
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
Net income continuous Operations
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
Minority interest income
Net income attributable to the parent company
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
Basic earnings per share
14.63%0.94
-6.33%0.74
-6.67%0.7
-16.75%3.28
54.64%0.9192
0.00%0.82
-31.30%0.79
-45.65%0.75
-0.76%3.94
-47.28%0.5944
Diluted earnings per share
14.63%0.94
-5.13%0.74
-6.67%0.7
-16.62%3.26
54.24%0.91
1.23%0.82
-31.58%0.78
-45.26%0.75
-0.76%3.91
-46.85%0.59
Dividend per share
7.84%0.55
7.84%0.55
7.84%0.55
8.51%2.04
8.51%0.51
8.51%0.51
8.51%0.51
8.51%0.51
4.44%1.88
4.44%0.47
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 4.85%10.64B4.00%10.38B2.23%9.96B-8.12%40.11B1.49%10.24B-2.56%10.14B-11.36%9.98B-18.06%9.75B1.34%43.65B-12.01%10.09B
Operating revenue 4.85%10.64B4.00%10.38B2.23%9.96B-8.12%40.11B1.49%10.24B-2.56%10.14B-11.36%9.98B-18.06%9.75B1.34%43.65B-12.01%10.09B
Cost of revenue 2.02%4.7B2.68%4.6B3.05%4.46B-6.10%17.98B-0.81%4.56B-0.52%4.61B-9.12%4.48B-13.15%4.33B3.26%19.14B-3.63%4.59B
Gross profit 7.20%5.94B5.08%5.77B1.57%5.5B-9.70%22.13B3.40%5.69B-4.20%5.54B-13.11%5.5B-21.60%5.42B-0.11%24.51B-17.96%5.5B
Operating expense 4.81%4.08B3.85%4.11B5.32%4.12B-3.05%15.66B-6.89%3.91B-2.99%3.89B0.13%3.95B-2.23%3.91B0.22%16.15B-3.01%4.19B
Selling and administrative expenses 6.32%2.9B7.15%2.94B7.13%2.96B-2.66%10.95B-8.38%2.72B-0.29%2.72B-0.62%2.74B-0.90%2.76B-0.67%11.25B-2.46%2.97B
Research and development costs 6.10%713M-2.38%698M4.59%684M-5.09%2.74B-3.45%700M-14.07%672M4.53%715M-6.17%654M5.32%2.89B-4.86%725M
Depreciation amortization depletion -5.24%470M-5.42%471M-3.87%472M-2.33%1.97B-3.02%481M-0.40%496M-1.78%498M-4.10%491M-1.66%2.01B-3.50%496M
-Depreciation and amortization -5.24%470M-5.42%471M-3.87%472M-2.33%1.97B-3.02%481M-0.40%496M-1.78%498M-4.10%491M-1.66%2.01B-3.50%496M
Operating profit 12.87%1.86B8.24%1.67B-8.15%1.39B-22.53%6.48B36.50%1.78B-6.95%1.65B-35.10%1.54B-48.18%1.51B-0.75%8.36B-45.16%1.3B
Net non-operating interest income expense 26.09%-51M4.92%-58M-17.31%-61M32.80%-252M-6.06%-70M19.77%-69M42.45%-61M55.56%-52M23.47%-375M45.00%-66M
Non-operating interest income -6.19%91M-16.33%82M-20.79%80M110.38%385M1.14%89M76.36%97M276.92%98M621.43%101M325.58%183M700.00%88M
Non-operating interest expense -14.46%142M-11.95%140M-7.84%141M14.16%637M3.25%159M17.73%166M20.45%159M16.79%153M4.69%558M17.56%154M
Other net income (expense) 41.94%132M-102.58%-4M5.71%111M37.30%438M3.66%85M25.68%93M89.02%155M29.63%105M15.58%319M18.84%82M
Gain on sale of security 10.00%11M128.57%6M-----1,950.00%-41M-271.43%-24M152.63%10M---21M-300.00%-6M-100.00%-2M133.33%14M
Other non- operating income (expenses) 45.78%121M-105.68%-10M0.00%111M49.22%479M60.29%109M-10.75%83M114.63%176M42.31%111M15.88%321M7.94%68M
Income before tax 16.10%1.94B-1.77%1.61B-8.07%1.44B-19.77%6.66B35.98%1.8B-4.95%1.67B-30.44%1.64B-45.69%1.56B1.16%8.31B-43.27%1.32B
Income tax 25.11%294M16.86%305M-13.52%211M-31.46%941M-29.97%201M-27.24%235M-21.86%261M-43.12%244M20.44%1.37B-15.09%287M
Net income 14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B
Net income continuous Operations 14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B
Minority interest income
Net income attributable to the parent company 14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B
Basic earnings per share 14.63%0.94-6.33%0.74-6.67%0.7-16.75%3.2854.64%0.91920.00%0.82-31.30%0.79-45.65%0.75-0.76%3.94-47.28%0.5944
Diluted earnings per share 14.63%0.94-5.13%0.74-6.67%0.7-16.62%3.2654.24%0.911.23%0.82-31.58%0.78-45.26%0.75-0.76%3.91-46.85%0.59
Dividend per share 7.84%0.557.84%0.557.84%0.558.51%2.048.51%0.518.51%0.518.51%0.518.51%0.514.44%1.884.44%0.47
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data